Precision medicine is reshaping therapeutic decisions. We discuss the current state and future directions.
Advances in genomic sequencing and bioinformatics have enabled clinicians to tailor treatments based on individual genetic profiles. Oncology has been at the forefront, where tumor genotyping guides targeted therapies that minimize side effects and maximize efficacy.
Beyond genetics, precision medicine platforms incorporate lifestyle data, biomarker assays, and environmental exposures to build a holistic patient model. This integrated approach supports preventive interventions and personalized monitoring plans.
Despite its promise, implementing precision medicine at scale requires interoperability across electronic health records, robust data governance, and clinician training to interpret complex datasets. Collaborative frameworks between healthcare systems, tech innovators, and regulatory bodies are vital for translating personalized insights into practice.